Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

ROGER TELL, CHRISTER SEDERHOLM, CLAES KLINTENBERG, LARS FRANKSSON, EVA BRANDÉN, GUNNAR HILLERDAL, ULF LÖNN, CARL-JOHAN LINDÉN, SVEN-BÖRJE EWERS, KRISTINA LAMBERG, EVA MRAZEK, BRITTA LÖDÉN, ANDERS SJÖGREN, THOMAS LINNÉ, SIGNE FRIESLAND and FLORIN SIRZÉN
Anticancer Research September 2008, 28 (5B) 2851-2857;
ROGER TELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tell_roger@lilly.com roger.tell@ki.se
CHRISTER SEDERHOLM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAES KLINTENBERG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LARS FRANKSSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVA BRANDÉN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GUNNAR HILLERDAL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ULF LÖNN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARL-JOHAN LINDÉN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SVEN-BÖRJE EWERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KRISTINA LAMBERG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVA MRAZEK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRITTA LÖDÉN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDERS SJÖGREN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS LINNÉ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIGNE FRIESLAND
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FLORIN SIRZÉN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 5B 2851-2857
PubMed 
19031924

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 18, 2008
  • Revision received June 30, 2008
  • Accepted July 7, 2008
  • Published online September 1, 2008.

Copyright & Usage 
Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ROGER TELL1,*,
  2. CHRISTER SEDERHOLM2,
  3. CLAES KLINTENBERG3,
  4. LARS FRANKSSON1,*,
  5. EVA BRANDÉN4,5,*,
  6. GUNNAR HILLERDAL4,
  7. ULF LÖNN6,
  8. CARL-JOHAN LINDÉN7,
  9. SVEN-BÖRJE EWERS8,
  10. KRISTINA LAMBERG9,*,
  11. EVA MRAZEK10,
  12. BRITTA LÖDÉN11,
  13. ANDERS SJÖGREN11,
  14. THOMAS LINNÉ12,
  15. SIGNE FRIESLAND1 and
  16. FLORIN SIRZÉN1,*
  1. 1Department of Oncology, Karolinska University Hospital, Stockholm
  2. 2Department of Pulmonary Medicine, Linköping University Hospital, Linköping
  3. 3Department of Oncology, Linköping University Hospital, Linköping
  4. 4Department of Pulmonary Medicine, Karolinska University Hospital, Stockholm
  5. 5Department of Respiratory Medicine, Gävle County Hospital, Gävle
  6. 6Department of Oncology, Gävle County Hospital, Gävle
  7. 7Department of Pulmonary Medicine, Lund University Hospital, Lund
  8. 8Department of Oncology, Lund University Hospital, Lund
  9. 9Department of Pulmonary Medicine, Västerås Central Hospital, Västerås
  10. 10Department of Oncology, Västerås Central Hospital, Västerås
  11. 11Department of Oncology, Karlstad Central Hospital, Karlstad
  12. 12Bristol-Myers Squibb AB, Bromma, Sweden
  1. Correspondence to: Roger Tell, MD, Ph.D. Eli Lilly Sweden AB, Gustav III Boulevard 42, Box 721, SE-169 27 Solna, Sweden. Tel: +46 706098892, e-mail: tell_roger{at}lilly.com; roger.tell{at}ki.se

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 28 (5B)
Anticancer Research
Vol. 28, Issue 5B
September-October 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
ROGER TELL, CHRISTER SEDERHOLM, CLAES KLINTENBERG, LARS FRANKSSON, EVA BRANDÉN, GUNNAR HILLERDAL, ULF LÖNN, CARL-JOHAN LINDÉN, SVEN-BÖRJE EWERS, KRISTINA LAMBERG, EVA MRAZEK, BRITTA LÖDÉN, ANDERS SJÖGREN, THOMAS LINNÉ, SIGNE FRIESLAND, FLORIN SIRZÉN
Anticancer Research Sep 2008, 28 (5B) 2851-2857;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
ROGER TELL, CHRISTER SEDERHOLM, CLAES KLINTENBERG, LARS FRANKSSON, EVA BRANDÉN, GUNNAR HILLERDAL, ULF LÖNN, CARL-JOHAN LINDÉN, SVEN-BÖRJE EWERS, KRISTINA LAMBERG, EVA MRAZEK, BRITTA LÖDÉN, ANDERS SJÖGREN, THOMAS LINNÉ, SIGNE FRIESLAND, FLORIN SIRZÉN
Anticancer Research Sep 2008, 28 (5B) 2851-2857;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire